Witryna10 kwi 2024 · Investors in Viking Therapeutics Inc (Symbol: VKTX) saw new options become available today, for the July 21st expiration. One of the key inputs that goes into the price an option buyer is willing ... Witryna13 kwi 2024 · -- Brian Lian, directeur, président et PDG, a vendu le 13 avril 2024 79 336 actions de Viking Therapeutics pour un montant de 1 463 749 dollars. Suite au dépôt du formulaire 4 auprès de la SEC ...
Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial …
Witryna29 gru 2024 · Viking Therapeutics accuses Chinese co of stealing fatty liver disease drug secrets By Blake Brittain The logo of Ascletis Pharma Inc. is seen at a news … Witryna11 kwi 2024 · SAN DIEGO , April 11, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation … creepy windows 10 themes
Viking Therapeutics Inc. (VKTX) Shares Up Despite Recent Market ...
WitrynaViking Therapeutics, Inc., a ‘…a clinical-stage #biopharmaceutical company focused on the development of #novel first-in-class or best-in-class therapies for… Rajesh Aggarwal MD PhD FRCS FACS on LinkedIn: Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Dual… Witryna11 kwi 2024 · The conference will take place April 17-20, 2024. Details for this presentation are as follows: 22nd Annual Needham Healthcare Conference. Details: … Witryna10 sty 2024 · SAN DIEGO, Jan. 10, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ... bucks waste charges